Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Accumulated Expenses: 2017-2023

Historic Accumulated Expenses for Solid Biosciences (SLDB) over the last 7 years, with Dec 2023 value amounting to $10.2 million.

  • Solid Biosciences' Accumulated Expenses rose 15.36% to $13.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $13.2 million, marking a year-over-year increase of 15.36%. This contributed to the annual value of $10.2 million for FY2023, which is 39.12% down from last year.
  • As of FY2023, Solid Biosciences' Accumulated Expenses stood at $10.2 million, which was down 39.12% from $16.7 million recorded in FY2022.
  • Over the past 5 years, Solid Biosciences' Accumulated Expenses peaked at $16.7 million during FY2022, and registered a low of $8.6 million during FY2020.
  • Its 3-year average for Accumulated Expenses is $12.1 million, with a median of $10.2 million in 2023.
  • As far as peak fluctuations go, Solid Biosciences' Accumulated Expenses soared by 75.18% in 2022, and later tumbled by 39.12% in 2023.
  • Yearly analysis of 5 years shows Solid Biosciences' Accumulated Expenses stood at $9.2 million in 2019, then fell by 5.86% to $8.6 million in 2020, then climbed by 10.28% to $9.5 million in 2021, then skyrocketed by 75.18% to $16.7 million in 2022, then crashed by 39.12% to $10.2 million in 2023.